Fig. 3From: Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapyThe antagonists of ECM stiffness regulators and mechano-signal transducers. Some of the inhibitors of collagen chaperone Hsp47, lysyl oxidases, mechanosensors Piezo1 and TRPV4, mechanotransducers integrin, ILK, FAK, YAP and TEAD are shownBack to article page